Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based medical research and telemedicine company with a clinic that provide ketamine treatments for persons with depression and related disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The Company is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. It seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. The Company has clinic operations in the Canadian cities of Mississauga, Kitchener-Waterloo, Ottawa and Montreal. Its subsidiary, Braxia Health, is engaged in offering rapid onset treatments to aid those suffering from several treatment-resistant conditions, such as depression and bipolar disorder.


CSE:BRAX - Post by User

Braxia Scientific Corp > This ridiculous company
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(27)
•••
Comment by Bronsonon Nov 23, 2020 1:34pm
195 Views
Post# 31953541

RE:RE:RE:RE:RE:This ridiculous company

RE:RE:RE:RE:RE:This ridiculous company

Correction 1.34 US before I get attacked I said 1.74US ... my mistake. 


so from 1.34 - .52 on a hault is NOT BAD it's not great and it sucks to wait and have no idea what's going on with the fear of total loss and your money in the hands of for lack of better words incompetent filers (whatever you'd call them) 

So we just wait on the news... hopefully the company gets investor intrest back and hopefully closes a few deals ... they were able to get their hands on 15M and they're using the money to expand. 


they might be incompetent at filings but at negotiating and branding ... they aren't you can see the data doesn't lie. They only fell once the hault happened and they couldn't tell anyone about what they were doing internally as a company with a few exceptions that they've mentioned in the e Mail below.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities